Trials / Unknown
UnknownNCT03631602
Posaconazole vs Itraconazole in Preventing IFD Post-HSCT
Posaconazole Oral Suspension and Itraconazole Oral Solution in Preventing Invasive Fungal Disease (IFD) in Patients With Hematopoietic Stem Cell Transplantation
- Status
- Unknown
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 120 (estimated)
- Sponsor
- Fujian Medical University · Academic / Other
- Sex
- All
- Age
- 13 Years
- Healthy volunteers
- Not accepted
Summary
Invasive Fungal Disease (IFD) after haematopoietic stem cell transplantation (HSCT) remain a clinical challenge.The studay aims to compare the efficacy and safety of posaconazole oral suspension vs itraconazole oral solution in preventing IFD post-HSCT.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | antifungal prophylaxis | posaconazole oral suspension vs itraconazole oral solution |
Timeline
- Start date
- 2017-10-01
- Primary completion
- 2019-10-01
- Completion
- 2020-04-01
- First posted
- 2018-08-15
- Last updated
- 2018-08-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT03631602. Inclusion in this directory is not an endorsement.